GRFS - Grifols SA Qarzning balans kapitallashuviga nisbati
Asosiy baholash vositasi bo'lib xizmat qiluvchi GURU.Markets platformasidagi ushbu grafik Grifols, S.A. (GRFS) aksiyalarining narx dinamikasini aks ettiradi, bu yerda qarzlarni kamaytirish uchun boshqaruv yollangan professionallarga o'tkazilgan va ko'rsatkich 1.50 darajasida turibdi. Kompaniya plazma markazlarini sotib olish va ilmiy sherikliklar orqali biologik preparatlar sektoridagi ta'sirini kengaytirmoqda. Shu bilan birga, Grifols, S.A. (GRFS) plazma fraksionallash ustidan ichki nazoratni saqlab qolgan holda, logistikani autsorsingga topshirmoqda.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_GRFS_-_Grifols-S.A._-_Debt-to-Net-Assets-Ratio "Grifols, S.A. - GRFS Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Grifols SA (GRFS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahliliyoti:Grifols, S.A. (GRFS)
Ushbu ko'rsatkich moliyaviy richagni baholash uchun kapital tuzilmasidagi umumiy majburiyatlar ulushini o'lchash orqali Grifols, S.A. (GRFS) kompaniyasining fundamental barqarorligini bozor tebranishlaridan ajratadi. Ushbu richag grafikasi — qarzning kitob kapitalizatsiyasiga nisbatini — tahlil qilish orqali investorlar boshqaruvni qayta tashkil etish risklarini kuzatishlari mumkin, plazma yig'ish marjalarining muvaffaqiyatli tiklanishi esa kompaniyaning o'z qarz yukini xavfsiz chegaralar doirasida saqlab qolish qobiliyatini tasdiqlaydi.
Grifols, S.A. kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar adaptivebiotech.com (ADPT)|Celldex Therapeutics, Inc. (CLDX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Aurinia Pharmaceuticals Inc (AUPH)|Balans kapitallashuviga qarzlar BCRX|Vera Corp - Sof aktivlarga qarzlar|DNTH: Qarzning balans kapitallashuviga nisbati|PHVS: Qarzning balans qiymatiga nisbati|ABCL (AbCellera Corp) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Tourmaline Bio Inc|PGEN (Intrexon) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PHAR|Qarzning balans kapitallashuviga nisbati Nektar Therapeutics NKTR|Qarzning balans qiymatiga nisbati upstreambio.com (UPB)|ZBIO: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Immunome Inc IMNM|Balans kapitallashuviga qarzlar GOSS|KALV: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Septerna Inc SEPN|pieris.com (PVLA) - Qarzning sof aktivlarga nisbati|SVRA: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Rigel Pharma|ANAB - Balans kapitallashuviga qarzlar|Qarzlarning balans kapitallashuviga nisbati ATXS (Astria Corp)|ENGN: Qarzning balans kapitallashuviga nisbati|RAPT Therapeutics Inc. - Balans qiymatiga qarzlar|JBIO - Qarzning balans kapitallashuviga nisbati|ACRS: Qarzning balans kapitallashuviga nisbati|Kyverna - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Tiziana Life Sciences, Ltd.|CABA - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati VTYX|THTX (Theratechnologies) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Avalo Therapeutics, Inc. AVTX|Qarzning balans qiymatiga nisbati ELDN|Sof aktivlarga qarzlar Agenus, Inc AGEN|Climb Bio Inc - Balans kapitallashuviga qarzlar|Zura Bio Ltd (ZURA) - Balans kapitallashuviga qarzlar|aTyr Pharma - Qarzning balans qiymatiga nisbati|Adagene Inc. (ADAG) - Sof aktivlarga qarzlar|ImageneBio - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati STTK|Equillium, Inc. (EQ) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati connectbiopharm.com (CNTB)|Immunic (IMUX) - Balans kapitallashuviga qarzlar|Atara Biotherapeutics, Inc. - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati IFRX (InflaRx GmbH)|XFOR: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati adicetbio.com (ACET)|Celularity (CELU) - Qarzlarning balans kapitallashuviga nisbati|INMB - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Barinthus Biotherapeutics PLC|Balans kapitallashuviga qarzlar KZR|Balans kapitallashuviga qarzlar SABS (SAB Biotherapeutics Inc)|Qarzning balans kapitallashuviga nisbati Akari Therapeutics|Enlivex Therapeutics Ltd - Qarzning sof aktivlarga nisbati|QTTB: Qarzning balans kapitallashuviga nisbati|GOVX - Qarzning balans qiymatiga nisbati|EDSA: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar iBio Corporation|CARM - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati xtlbio.com|BOLT (Bolt Biotherapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar HCWB (hcwbiologics.com)|Aptevo Therapeutics Inc. - Qarzning balans kapitallashuviga nisbati|AIM ImmunoTech, Inc. - Qarzning balans qiymatiga nisbati|ADTX: Qarzning balans kapitallashuviga nisbati|gribio.com (GRI) - Qarzning balans qiymatiga nisbati|XRTX: Qarzning balans qiymatiga nisbati|HIND (Vyome Holdings Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Revelation Bio (REVB)|Qarzning balans qiymatiga nisbati Indaptus Corp|Scinai Immunotherapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar calcimedica.com (CALI)|AFMD (Affimed N.V.) - Balans kapitallashuviga qarzlar|Allakos Inc - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati HOOKIPA (HOOK)|IGMS - Qarzning sof aktivlarga nisbati|iTeos Therapeutics - Balans kapitallashuviga qarzlar|oceanbiomedical.com (OCEA) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar TC BioPharm TCBP|Qarzlarning balans kapitallashuviga nisbati THRD